{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:30:56Z","timestamp":1792614656995,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaci.2015.06.032","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T16:03:56Z","timestamp":1440432236000},"page":"1277-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":251,"title":["Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing"],"prefix":"10.1016","volume":"136","author":[{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judilyn","family":"Fuentes-Duculan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Czernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Shemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.06.032_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/jidsymp.2013.4","article-title":"Overview of alopecia areata","volume":"16","author":"Hordinsky","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2015.06.032_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1684\/ejd.2013.2042","article-title":"Cytokine pathways and interactions in alopecia areata","volume":"23","author":"Giordano","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2012.08.010","article-title":"Alopecia areata update","volume":"31","author":"Alkhalifah","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2015.06.032_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2015.06.032_bib6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/bjd.13559","article-title":"The global burden of disease associated with alopecia areata","volume":"172","author":"Karimkhani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","article-title":"The genetics of alopecia areata: new approaches, new findings, new treatments","volume":"78","author":"Biran","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2015.06.032_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4103\/0378-6323.116725","article-title":"Alopecia areata: an update","volume":"79","author":"Seetharam","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2015.06.032_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1529-8019.2011.01413.x","article-title":"Alopecia areata: Clinical presentation, diagnosis, and unusual cases","volume":"24","author":"Finner","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2015.06.032_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2011.01476.x","article-title":"Advances in the management of alopecia areata","volume":"39","author":"Ito","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib14","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/jdv.12009","article-title":"Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata","volume":"27","author":"Luk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2015.06.032_bib15","doi-asserted-by":"crossref","first-page":"304370","DOI":"10.1155\/2014\/304370","article-title":"Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects","volume":"2014","author":"Aghaei","year":"2014","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-7753.66920","article-title":"Intralesional steroids for alopecia areata","volume":"2","author":"Kumaresan","year":"2010","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaci.2015.06.032_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1529-8019.2011.01419.x","article-title":"Topical and intralesional therapies for alopecia areata","volume":"24","author":"Alkhalifah","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2015.06.032_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaad.2015.01.008","article-title":"Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series","volume":"72","author":"Durdu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/ijd.12226","article-title":"Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience","volume":"52","author":"El Khoury","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaci.2015.06.032_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5021\/ad.2013.25.1.12","article-title":"Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design","volume":"25","author":"Park","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5021\/ad.2013.25.4.471","article-title":"Early intervention with high-dose steroid pulse therapy prolongs disease-free interval of severe alopecia areata: a retrospective study","volume":"25","author":"Yang","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2003.00654.x","article-title":"PUVA treatment of alopecia areata totalis and universalis: a retrospective study","volume":"44","author":"Whitmont","year":"2003","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/exd.12489","article-title":"The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata","volume":"23","author":"Ito","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.1996.tb01149.x","article-title":"In\u00a0vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata","volume":"135","author":"McElwee","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1354\/vp.40-6-643","article-title":"Alopecia areata in C3H\/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss","volume":"40","author":"McElwee","year":"2003","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jaci.2015.06.032_bib29","doi-asserted-by":"crossref","first-page":"928030","DOI":"10.1155\/2010\/928030","article-title":"Cytokines and other mediators in alopecia areata","volume":"2010","author":"Gregoriou","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2015.06.032_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/exd.12209","article-title":"What causes alopecia areata?","volume":"22","author":"McElwee","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.jidsp.5640218","article-title":"The potential role of cytokines and T cells in alopecia areata","volume":"4","author":"Hoffmann","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2015.06.032_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygeno.2010.05.002","article-title":"Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures","volume":"96","author":"Subramanya","year":"2010","journal-title":"Genomics"},{"key":"10.1016\/j.jaci.2015.06.032_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00403-006-0700-2","article-title":"In\u00a0vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis","volume":"298","author":"Katagiri","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2015.06.032_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00403-015-1539-1","article-title":"Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2015.06.032_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2015.06.032_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/2229-5178.131076","article-title":"Total serum immunoglobulin E in patients with alopecia areata","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaci.2015.06.032_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients","volume":"42","author":"Avitabile","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2015.06.032_bib40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib41","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/jid.2010.166","article-title":"Effective narrow-band UVB radiation therapy suppresses the IL-23\/IL-17 axis in normalized psoriasis plaques","volume":"130","author":"Johnson-Huang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib42","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib43","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2007.03.006","article-title":"Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis","volume":"119","author":"Guttman-Yassky","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","article-title":"Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis","volume":"132","author":"Suarez-Farinas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2105-6-294","article-title":"Harshlight: a \u201ccorrective make-up\u201d program for microarray chips","volume":"6","author":"Suarez-Farinas","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2015.06.032_bib47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","volume":"99","author":"Wu","year":"2004","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jaci.2015.06.032_bib48","doi-asserted-by":"crossref","first-page":"e17238","DOI":"10.1371\/journal.pone.0017238","article-title":"Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2015.06.032_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jaci.2015.06.032_bib50","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2326-6066.CIR-13-0199-T","article-title":"IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization","volume":"2","author":"Ohmatsu","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaci.2015.06.032_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1087-0024.2005.10112.x","article-title":"Human hair keratin-associated proteins","volume":"10","author":"Shimomura","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2015.06.032_bib52","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.yexcr.2007.02.032","article-title":"Hair follicle-specific keratins and their diseases","volume":"313","author":"Schweizer","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jaci.2015.06.032_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0190-9622(87)70096-6","article-title":"Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","article-title":"History of atopy or autoimmunity increases risk of alopecia areata","volume":"61","author":"Barahmani","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib56","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5021\/ad.2014.26.6.722","article-title":"Differences in comorbidity profiles between early-onset and late-onset\u00a0alopecia areata patients: a retrospective study of 871 Korean patients","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib58","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcp.24441","article-title":"Regulation of cellular processes by interleukin-16 in homeostasis and cancer","volume":"229","author":"Richmond","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2015.06.032_bib60","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/rheumatology\/37.12.1334","article-title":"Circulating interleukin-16 in systemic lupus erythematosus","volume":"37","author":"Lee","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ijd.12251","article-title":"Association between IL16 gene polymorphisms and susceptibility to alopecia areata in the Korean population","volume":"53","author":"Lew","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jdermsci.2004.09.006","article-title":"Interleukin-16 in patients with alopecia areata","volume":"37","author":"Tanyasiri","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2015.06.032_bib63","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaci.2015.06.032_bib64","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1517\/14740338.2015.1031743","article-title":"Drug safety evaluation of apremilast for treating psoriatic arthritis","volume":"14","author":"Busa","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaci.2015.06.032_bib65","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archdermatol.2012.812","article-title":"A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults","volume":"148","author":"Samrao","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2014.11.009","article-title":"The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in\u00a0vivo","volume":"77","author":"Keren","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2015.06.032_bib67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/eji.200738051","article-title":"IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes","volume":"38","author":"Kanda","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib68","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0625.2007.00643.x","article-title":"Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties","volume":"17","author":"Yu","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib70","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-2133.1996.d01-1099.x","article-title":"Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in\u00a0vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata","volume":"135","author":"Philpott","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib71","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1006\/bbrc.2001.6324","article-title":"Interferon Beta secreted from human hair dermal papilla cells inhibits the growth of outer root sheath cells cultured in\u00a0vitro","volume":"290","author":"Kim","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2015.06.032_bib72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2005.06453.x","article-title":"Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles","volume":"152","author":"Ito","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib73","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaad.2014.03.005","article-title":"Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study","volume":"70","author":"Tauber","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib76","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/jid.2013.503","article-title":"In\u00a0vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans","volume":"134","author":"Omori-Miyake","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2340\/0001555576421423","article-title":"Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis)","volume":"76","author":"Teraki","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2015.06.032_bib78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.2009.03523.x","article-title":"Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy","volume":"35","author":"Barahmani","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib79","first-page":"212","article-title":"Serum concentrations of interferon-gamma (IFN-g) in patients with alopecia areata: correlation with clinical type and duration of the disease","volume":"64","author":"Kasumagic-Halilovic","year":"2010","journal-title":"Med Arh"},{"key":"10.1016\/j.jaci.2015.06.032_bib80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaci.2014.11.015","article-title":"The translational revolution and use of biologics in patients with inflammatory skin diseases","volume":"135","author":"Noda","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib81","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2015.03.003","article-title":"RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications","volume":"135","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaip.2014.03.006","article-title":"Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications","volume":"2","author":"Czarnowicki","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2015.06.032_bib83","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cyto.2014.11.023","article-title":"New pathogenic and therapeutic paradigms in atopic dermatitis","volume":"73","author":"Malajian","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2015.06.032_bib85","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10799900260286641","article-title":"Alopecia of IFN-gamma knockout mouse as a model for disturbance of the hair cycle: a unique arrest of the hair cycle at the anagen phase accompanied by mitosis","volume":"22","author":"Hirota","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaci.2015.06.032_bib86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.12273","article-title":"Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata","volume":"40","author":"Inui","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygeno.2011.08.009","article-title":"Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata","volume":"98","author":"Coda","year":"2011","journal-title":"Genomics"},{"key":"10.1016\/j.jaci.2015.06.032_bib88","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2230.2005.01817.x","article-title":"In\u00a0vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101","volume":"30","author":"Shohat","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib89","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gene.2013.05.086","article-title":"The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population","volume":"527","author":"Kalkan","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.jaci.2015.06.032_bib91","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2015.06.032_bib92","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib93","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib94","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib95","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A\u00a0in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib96","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","article-title":"Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis","volume":"133","author":"Sofen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib97","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib98","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib99","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2014.05.046","article-title":"Humanized anti-IFN-\u03b3 (HuZAF) in the treatment of psoriasis","volume":"135","author":"Harden","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.06.032_bib100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chembiol.2011.01.012","article-title":"Jak1 has a dominant role over Jak3 in signal transduction through \u03b3c-containing cytokine receptors","volume":"18","author":"Haan","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.jaci.2015.06.032_bib101","first-page":"e24137","article-title":"The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis","volume":"2","author":"Bao","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.jaci.2015.06.032_bib102","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib103","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","article-title":"Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis","volume":"134","author":"Craiglow","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000353159","article-title":"Comparison of interleukin-17- producing cells in different clinical types of alopecia areata","volume":"227","author":"Tojo","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2015.06.032_bib105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib106","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2340\/00015555-1613","article-title":"Clinical and histopathological features of itch in patients with alopecia areata","volume":"93","author":"Yamakoshi","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2015.06.032_bib107","doi-asserted-by":"crossref","first-page":"503587","DOI":"10.1155\/2010\/503587","article-title":"Serum Interleukin-4 and total immunoglobulin E in nonatopic alopecia areata patients and HLA-DRB1 typing","volume":"2010","author":"Attia","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.jaci.2015.06.032_bib108","first-page":"149","article-title":"Serum levels of total immunoglobulin e in patients with alopecia areata: relationship with clinical type of the disease","volume":"14","author":"Kasumagic-Halilovic","year":"2006","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaci.2015.06.032_bib109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajd.12065","article-title":"Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum","volume":"54","author":"Zhang","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaci.2015.06.032_bib110","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.06.032_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.00223411","article-title":"A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma","volume":"41","author":"Piper","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2015.06.032_bib112","first-page":"2831","article-title":"Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab","volume":"17","author":"Andrisani","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915009318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915009318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:56:31Z","timestamp":1758790591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915009318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0091674915009318"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.06.032","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}